ABOUT EVENT

What Can You Expert at the 4th Circular & Self-Amplifying RNA Therapeutics Summit!

Curated in collaboration with key stakeholders, the 4th Circular & Self-Amplifying RNA Therapeutics Summit returns as the only industry dedicated event showcasing the latest approaches and applications of these next generation RNAs for more potent and durable treatment of a wide array of diseases.

Industry experts will navigate through presentations and interactive discussions to:

OPTIMIZE
self-amplifying mRNA sequence design as well as circularization of mRNA to achieve improved stability, durability and functionality for more potent and efficacious therapeutics with Virogin Biotech & CSL Seqirus

Optimize Icon

ACHIEVE
efficient RNA encapsulation and specificity with new and innovative formulations for safe and targeted delivery of circular and self-amplifying RNA with HDT Bio & Stealth-Mode Biotech Company

Achieve icon (1)

IMPROVE
purity and scalability through navigating manufacturing and analytical challenges for attaining large-scale production of high-quality circular and self-amplifying RNA therapies with Merck & Co & Immunomic Therapeutics

Improve icon

UNDERSTAND
the full potential of next generation RNAs and their benefits over linear mRNA for treating a wide array of diseases with Sail Biomedicines, RiboX Therapeutics & Replicate Bioscience 

Understand icon (1)

BOOST
investment of circular and self-amplifying RNAs by hearing insights into the current trends and key priority applications with MPM Capital & Orbital Therapeutics

Boost Icon (1)

Key Sessions Showcasing Brand New Data

4th Circular Self-Amplifying RNA Therapeutics Summit 2025 - logo

Engineering Sa-mRNA Structure to Improve Vaccine Product Stability & Functionality

Fei Liu, Associate Director, Molecular Biology, CSL Seqirus

CSL Seqirus - company logo - Circular & saRNA Therapeutics 2025
4th Circular Self-Amplifying RNA Therapeutics Summit 2025 - logo

Advancing Analytical Methods Enabling Circular RNA Pharmaceutical Preparedness

Nichole Lareau, Associate Principal Scientist, Merck & Co

Merck - Company Logo - Circular & Self-Amplifying RNA Therapeutics
4th Circular Self-Amplifying RNA Therapeutics Summit 2025 - logo

In Vivo Reversible Programming of T cells with SAIL’s Targeted NP-eRNA Platform for Treatment of Autoimmune Diseases & Beyond

Michael Mingueneau, Head, Immunology, Sail Biomedicines

Sail Biomedicines
4th Circular Self-Amplifying RNA Therapeutics Summit 2025 - logo

Circular RNA: Transforming a Promising Technology into Cutting-Edge Therapeutics

Edo Kon, Director, Business Development, RiboX Therapeutics

Ribox Therapeutics - company logo - Circular saRNA Therapeutics
4th Circular Self-Amplifying RNA Therapeutics Summit 2025 - logo

Myeloid Cell Targeting Cancer Immunotherapy via Localized Gene Delivery with Alphavirus Replicon Particles (VRP) Expressing IL-12 

Momoko Ishikawa, Senior Scientist, VLP Therapeutics

VLP Therapeutics

New Companies For 2025

CSL Seqirus - Circular & Self-Amplifying RNA Therapeutics
Merck - Circular & Self-Amplifying RNA Therapeutics
VLP Therapeutics - Circular & Self-Amplifying RNA Therapeutics
Ribox Therapeutics - Circular & Self-Amplifying RNA Therapeutics
Circular & Self-Amplifying RNA Therapeutics

What Your Peers Have to Say:

“Engage with thought leaders in our field to foster collaboration and drive advancements"

Edo Kon, Director, Business Development

RiboX Therapeutics - Circular & Self-Amplifying RNA Therapeutics

“Attending the Circular & Self-Amplifying RNA Therapeutics Summit would provide valuable insights into the latest innovations in RNA-based therapies, which is essential for staying at the forefront of the field. It offers an excellent opportunity to network with industry leaders, exchange ideas, and explore potential collaborations”

Dinesh Chandra, Lead Consultant Scientist

Stealthmode - Circular & Self-Amplifying RNA Therapeutics